TPG wraps up inaugural life sciences fund
The closing brings total capital raised to $580 million for the overall strategy, which includes a portion of commitments from The Rise Fund.
6 August 2024•1 min read
The closing brings total capital raised to $580 million for the overall strategy, which includes a portion of commitments from The Rise Fund.
Mid-market stalwart Kohlberg stands pat with $5bn target for Fund XI
27 October 2026 · 3 mins read
GTCR closes in on $15bn hard-cap for Fund XV
26 October 2026 · 2 mins read
Meet the family: PPC is sticking to what it knows best
23 October 2026 · 3 mins read
Gainline Capital upsizes target for Fund III
22 October 2026 · 2 mins read
KKR’s Alisa Wood: PE isn’t worth it if you can’t access top GPs
21 October 2026 · 3 mins read
LACERA to reduce meeting frequency despite governance concerns
21 October 2026 · 3 mins read
Retiring SBCERA CIO leaves income-focused private markets playbook for successor
20 October 2026 · 3 mins read
